
2025 China Apheresis Market Revenue Opportunities Report
Description
The 2025 China Apheresis Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the China apheresis market are Terumo Corporation (Terumo BCT Inc.), Fresenius SE & Co. KGaA, Haemonetics Corporation, and Asahi Kasei Corporation. These companies are key players globally and hold significant presence in China, contributing to the market's rapid growth driven by increasing demand for plasma-based therapies and therapeutic apheresis treatments.
Terumo BCT leads with advanced apheresis systems like the Spectra Optia, widely adopted for automated red blood cell exchange and therapeutic apheresis, supporting hospitals and blood centers in China. Fresenius focuses on donor and therapeutic products through its Fresenius Kabi and Medical Care divisions, promoting research and expanding in emerging markets including China. Haemonetics offers innovative plasmapheresis and plateletpheresis devices, marketing products in about 90 countries with deep market penetration in Asia-Pacific. Asahi Kasei is recognized for disposable kits and devices, supporting local plasma collection efforts enhanced by government initiatives under the Healthy China 2030 strategy. All four are integral to the rapid growth of China’s apheresis equipment market, expected to grow at over 12% CAGR from 2024 to 2030.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the China apheresis market are Terumo Corporation (Terumo BCT Inc.), Fresenius SE & Co. KGaA, Haemonetics Corporation, and Asahi Kasei Corporation. These companies are key players globally and hold significant presence in China, contributing to the market's rapid growth driven by increasing demand for plasma-based therapies and therapeutic apheresis treatments.
Terumo BCT leads with advanced apheresis systems like the Spectra Optia, widely adopted for automated red blood cell exchange and therapeutic apheresis, supporting hospitals and blood centers in China. Fresenius focuses on donor and therapeutic products through its Fresenius Kabi and Medical Care divisions, promoting research and expanding in emerging markets including China. Haemonetics offers innovative plasmapheresis and plateletpheresis devices, marketing products in about 90 countries with deep market penetration in Asia-Pacific. Asahi Kasei is recognized for disposable kits and devices, supporting local plasma collection efforts enhanced by government initiatives under the Healthy China 2030 strategy. All four are integral to the rapid growth of China’s apheresis equipment market, expected to grow at over 12% CAGR from 2024 to 2030.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.